Carson Wealth (CWM LLC)’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$0	Hold	4	–	–	﹤0.01%	3042
2021 Q1	$0	Hold	4	–	–	﹤0.01%	3039
2020 Q4	$0	Hold	4	–	–	﹤0.01%	3036
2020 Q3	$0	Hold	4	–	–	﹤0.01%	3032
2020 Q2	$0	Hold	4	–	–	﹤0.01%	3030
2020 Q1	$0	Hold	4	–	–	﹤0.01%	3027
2019 Q4	$0	Hold	4	–	–	﹤0.01%	3025
2019 Q3	$0	Hold	4	–	–	﹤0.01%	3025
2019 Q2	$0	Hold	4	–	–	﹤0.01%	3024
2019 Q1	$0	Buy	+4	New	+$217	﹤0.01%	3368

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s EVFM Position: Q2 2021 in Review

Carson Wealth (CWM LLC) held its Evofem Biosciences, Inc. Common Stock (EVFM) position steady in Q2 2021 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3042.

Carson Wealth (CWM LLC) first reported a position in EVFM in Q1 2019 and has held it in 10 quarters since. 81 funds tracked by Wall St. Rank hold EVFM as of Q2 2021.

Carson Wealth (CWM LLC) held 4 shares of Evofem Biosciences, Inc. Common Stock worth $0 as of Q2 2021.
Carson Wealth (CWM LLC) left its Evofem Biosciences, Inc. Common Stock share count unchanged in Q2 2021.
Evofem Biosciences, Inc. Common Stock made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q2 2021, its #3042 holding.
Carson Wealth (CWM LLC) first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2019 and has held it in 10 quarters since.
81 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2021.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2021, filed 29 Jul 2021.